Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

1201920-88-8

Ketotriclabendazole

1201920-88-8
1867-66-9

Ketamine HCl USP

1867-66-9
29701-07-3

Kanamycin B sulfate salt

29701-07-3
19408-46-9

Kasugamycin HCl

19408-46-9
88456-70-6

Ketotifen N-oxide

88456-70-6
520-18-3

Kaempferol

520-18-3
74103-07-4

Ketorolac Tromethamine

74103-07-4
124750-99-8

Losartan potassium

124750-99-8
846-49-1

Lorazepam

846-49-1
103577-45-3

Lansoprazole

103577-45-3
13010-47-4

Lomustine

13010-47-4
61312-87-6

Lactam

61312-87-6
1441674-54-9

Ledipasvir acetone

1441674-54-9
96-82-2

Lactobionic Acid (mixture of Acid form and Lactone form)

96-82-2
100986-85-4

Levofloxacin

100986-85-4
303-34-4

Lasiocarpine

303-34-4
127-30-0

Lasiocarpine N-oxide

127-30-0
10285-07-1

Lycopsamine

10285-07-1
1217716-71-6

Levofloxacin D8

1217716-71-6
102767-28-2

Levetiracetam

102767-28-2